In Vitro Effect of Clinical Propofol Concentrations on Platelet Aggregation

Hye Gyo Chung, Soohyun A. Myung, Ho Sung Son, Yun-Hee Kim, Jin Namgung, Mi La Cho, Hyuk Choi, Choon Hak Lim

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The inhibitory effect of propofol on platelet aggregation remains unclear, and studies on the subject disagree. Furthermore, although propofol infusions are widely used for general anesthesia and as sedatives for patients in intensive care units, little information is available on its concentration- and time-related effects on platelet aggregation. Here, the authors investigated the in vitro effect of propofol, at concentrations required for sedation and general anesthesia, on platelet aggregation after 1, 2, or 3h. Blood from healthy volunteers (n=9) was incubated at propofol plasma concentrations of 0, 2, 4, and 10μg/mL in a water bath at 37°C. Platelet aggregation was measured using a platelet function analyzer (PFA-100) after 1, 2, or 3h of incubation. Times to occlude collagen/epinephrine (CEPI) or collagen/adenosine 5'-diphosphate (CADP)-coated membranes (closure times, CTs) were measured. The CEPI and CADP CTs of non-incubated blood were 125.6±19.5s and 93.0±12.2s, respectively, and no significant difference in CEPI CTs was observed at propofol plasma concentrations of 0, 2, 4, and 10μg/mL after incubation for 1, 2, or 3h. CADP CTs were comparable at propofol concentrations of 0, 2, 4, and 10μg/mL at each incubation time. These findings suggest that propofol at concentrations required for sedation and general anesthesia has no inhibitory effect on platelet aggregation after 3h of incubation.

Original languageEnglish
JournalArtificial Organs
Volume37
Issue number1
DOIs
Publication statusPublished - 2013 Jan 1

Fingerprint

Propofol
Platelets
Platelet Aggregation
Collagen
Agglomeration
Diphosphates
Adenosine
Adenosine Diphosphate
General Anesthesia
Epinephrine
Blood
Plasmas
Intensive care units
In Vitro Techniques
Hypnotics and Sedatives
Baths
Intensive Care Units
Healthy Volunteers
Blood Platelets
Membranes

Keywords

  • In vitro
  • Platelet aggregation
  • Propofol anesthesia

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Bioengineering
  • Medicine (miscellaneous)

Cite this

In Vitro Effect of Clinical Propofol Concentrations on Platelet Aggregation. / Chung, Hye Gyo; Myung, Soohyun A.; Son, Ho Sung; Kim, Yun-Hee; Namgung, Jin; Cho, Mi La; Choi, Hyuk; Lim, Choon Hak.

In: Artificial Organs, Vol. 37, No. 1, 01.01.2013.

Research output: Contribution to journalArticle

Chung, Hye Gyo ; Myung, Soohyun A. ; Son, Ho Sung ; Kim, Yun-Hee ; Namgung, Jin ; Cho, Mi La ; Choi, Hyuk ; Lim, Choon Hak. / In Vitro Effect of Clinical Propofol Concentrations on Platelet Aggregation. In: Artificial Organs. 2013 ; Vol. 37, No. 1.
@article{7dbde196846b4cecbfa817e7253adfb2,
title = "In Vitro Effect of Clinical Propofol Concentrations on Platelet Aggregation",
abstract = "The inhibitory effect of propofol on platelet aggregation remains unclear, and studies on the subject disagree. Furthermore, although propofol infusions are widely used for general anesthesia and as sedatives for patients in intensive care units, little information is available on its concentration- and time-related effects on platelet aggregation. Here, the authors investigated the in vitro effect of propofol, at concentrations required for sedation and general anesthesia, on platelet aggregation after 1, 2, or 3h. Blood from healthy volunteers (n=9) was incubated at propofol plasma concentrations of 0, 2, 4, and 10μg/mL in a water bath at 37°C. Platelet aggregation was measured using a platelet function analyzer (PFA-100) after 1, 2, or 3h of incubation. Times to occlude collagen/epinephrine (CEPI) or collagen/adenosine 5'-diphosphate (CADP)-coated membranes (closure times, CTs) were measured. The CEPI and CADP CTs of non-incubated blood were 125.6±19.5s and 93.0±12.2s, respectively, and no significant difference in CEPI CTs was observed at propofol plasma concentrations of 0, 2, 4, and 10μg/mL after incubation for 1, 2, or 3h. CADP CTs were comparable at propofol concentrations of 0, 2, 4, and 10μg/mL at each incubation time. These findings suggest that propofol at concentrations required for sedation and general anesthesia has no inhibitory effect on platelet aggregation after 3h of incubation.",
keywords = "In vitro, Platelet aggregation, Propofol anesthesia",
author = "Chung, {Hye Gyo} and Myung, {Soohyun A.} and Son, {Ho Sung} and Yun-Hee Kim and Jin Namgung and Cho, {Mi La} and Hyuk Choi and Lim, {Choon Hak}",
year = "2013",
month = "1",
day = "1",
doi = "10.1111/j.1525-1594.2012.01553.x",
language = "English",
volume = "37",
journal = "Artificial Organs",
issn = "0160-564X",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - In Vitro Effect of Clinical Propofol Concentrations on Platelet Aggregation

AU - Chung, Hye Gyo

AU - Myung, Soohyun A.

AU - Son, Ho Sung

AU - Kim, Yun-Hee

AU - Namgung, Jin

AU - Cho, Mi La

AU - Choi, Hyuk

AU - Lim, Choon Hak

PY - 2013/1/1

Y1 - 2013/1/1

N2 - The inhibitory effect of propofol on platelet aggregation remains unclear, and studies on the subject disagree. Furthermore, although propofol infusions are widely used for general anesthesia and as sedatives for patients in intensive care units, little information is available on its concentration- and time-related effects on platelet aggregation. Here, the authors investigated the in vitro effect of propofol, at concentrations required for sedation and general anesthesia, on platelet aggregation after 1, 2, or 3h. Blood from healthy volunteers (n=9) was incubated at propofol plasma concentrations of 0, 2, 4, and 10μg/mL in a water bath at 37°C. Platelet aggregation was measured using a platelet function analyzer (PFA-100) after 1, 2, or 3h of incubation. Times to occlude collagen/epinephrine (CEPI) or collagen/adenosine 5'-diphosphate (CADP)-coated membranes (closure times, CTs) were measured. The CEPI and CADP CTs of non-incubated blood were 125.6±19.5s and 93.0±12.2s, respectively, and no significant difference in CEPI CTs was observed at propofol plasma concentrations of 0, 2, 4, and 10μg/mL after incubation for 1, 2, or 3h. CADP CTs were comparable at propofol concentrations of 0, 2, 4, and 10μg/mL at each incubation time. These findings suggest that propofol at concentrations required for sedation and general anesthesia has no inhibitory effect on platelet aggregation after 3h of incubation.

AB - The inhibitory effect of propofol on platelet aggregation remains unclear, and studies on the subject disagree. Furthermore, although propofol infusions are widely used for general anesthesia and as sedatives for patients in intensive care units, little information is available on its concentration- and time-related effects on platelet aggregation. Here, the authors investigated the in vitro effect of propofol, at concentrations required for sedation and general anesthesia, on platelet aggregation after 1, 2, or 3h. Blood from healthy volunteers (n=9) was incubated at propofol plasma concentrations of 0, 2, 4, and 10μg/mL in a water bath at 37°C. Platelet aggregation was measured using a platelet function analyzer (PFA-100) after 1, 2, or 3h of incubation. Times to occlude collagen/epinephrine (CEPI) or collagen/adenosine 5'-diphosphate (CADP)-coated membranes (closure times, CTs) were measured. The CEPI and CADP CTs of non-incubated blood were 125.6±19.5s and 93.0±12.2s, respectively, and no significant difference in CEPI CTs was observed at propofol plasma concentrations of 0, 2, 4, and 10μg/mL after incubation for 1, 2, or 3h. CADP CTs were comparable at propofol concentrations of 0, 2, 4, and 10μg/mL at each incubation time. These findings suggest that propofol at concentrations required for sedation and general anesthesia has no inhibitory effect on platelet aggregation after 3h of incubation.

KW - In vitro

KW - Platelet aggregation

KW - Propofol anesthesia

UR - http://www.scopus.com/inward/record.url?scp=84872372956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872372956&partnerID=8YFLogxK

U2 - 10.1111/j.1525-1594.2012.01553.x

DO - 10.1111/j.1525-1594.2012.01553.x

M3 - Article

C2 - 23145919

AN - SCOPUS:84872372956

VL - 37

JO - Artificial Organs

JF - Artificial Organs

SN - 0160-564X

IS - 1

ER -